COMPASS Pathways (NASDAQ:CMPS – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Cantor Fitzgerald in a note issued to investors on Thursday, Benzinga reports. Other equities research analysts have also recently issued reports about the stock. HC Wainwright reaffirmed a “buy” rating and issued a $120.00 target price on shares […]